“…3 Subsequently, many scholars found that PRL-3 was highly expressed in many tumours, such as breast cancer, ovarian cancer, intestinal cancer, gliomas and stomach cancer, and was closely related to metastasis. 4-8 PRL-3 expression has also been reported in a Hodgkin's lymphoma cell line, 9 melanomas, liver, ovarian, breast and gastric cancers, where its presence seems to have an important role in the acquisition of metastatic potential of tumour cells. 10,11 Consistent with the role of PRL-3 over-expression in metastasis, its ectopic expression in different cell types is correlated with the induction of metastatic phenotypes, such as invasion and motility capabilities.…”